This test panel includes
- 11 Panel drug Screen
- Hep B Surface Ab, Qual
- QuantiFERON-TB Gold Plus
- Varicella-Zoster V Ab, IgG
- Measles/Mumps/Rubella Immunity Titer
- TDAP Titer
Complete Employer Panel
iHLTH will send your lab order, via secured email, within 24 hours of order completion Monday - Friday 8:30 AM - 4:30 PM EST to the email you provide during checkout.
11 Panel Drug Screen Includes
6-Acetyl Morphine
Amphetamines
Barbiturates
Benzodiazepines
Buprenorphine
Cocaine
MDMA
Marijuana Metab
Methadone
Opiates
Oxycodone
PCP
Propoxyphene
Bordetella pertussis Antibodies, IgG
Establish evidence of infection/exposure to Bordetella pertussis, the causative agent of whooping cough
Tetanus/Diphtheria Antibody Profile
Diphtheria antitoxoid antibodies; tetanus antitoxoid antibodies
Hepatitis B Surface Antibody, Qualitative
Presence of antibody to hepatitis B surface antigen (anti-HBs) is used to determine immune status to HBV or disease progression in individuals infected with HBV. Anti-HBs levels can be measured to determine if vaccination is needed, or following a vaccination regimen, to determine if protective immunity has been achieved.
QuantiFERON®-TB Gold Plus
QuantiFERON-TB Gold Plus is an in vitro diagnostic test using a peptide cocktail of CD4+ and CD8+ T cell antigens to stimulate cells in heparinized whole blood. Detection of interferon-gamma by enzyme-linked immunosorbent assay (ELISA) is used to identify in vitro responses to these peptide antigens that are associated with Mycobacterium tuberculosis infection. QuantiFERON-TB Gold Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations.
Varicella Zoster Virus (VZV) Antibodies, IgG
This test is used for qualitative detection of specific IgG antibodies to varicella-zoster virus (VZV) to aid in the identification of previous infection with VZV and/or vaccination against VZV.
Measles, Mumps, Rubella (MMR) Immunity Profile
This test is used to aid in the determination of serological status to measles, mumps, and rubella viruses. A positive result generally indicates exposure to virus or previous vaccination. A positive result is considered adequate laboratory evidence of immunity.